All Insights
Showing 97 - 108 of 240
Life Sciences and Healthcare
Government set to introduce new legislation to facilitate gene editing in plants
The UK wants genetic technologies used for agricultural innovation, but the commercial path and patent position remain unclear
Life Sciences and Healthcare
2021 Life Sciences Patent Case Review
The UK Patents court has had an active year – we review 18 of the principal cases for the sector
Life Sciences and Healthcare
Medical device advertising in Italy: is authorisation by the Ministry of Health still required?
Italian Ministry of Health departs from harmonised EU regulatory framework on advertising medical devices by continuing authorisation regime
Life Sciences and Healthcare
Patient support programs: comments on Royal Decree 957/2020
Should patient support programs meet the requirements provided for non-interventional studies? Despite its brief regulation, patient support programs sparked debate
Life Sciences and Healthcare
2022 Finance Act increases State investment in Italian national health system
Pharmaceutical spending ceilings are increased and reforms to technical standards are expected
Life Sciences and Healthcare
Global healthcare's embrace of patient support programmes spurs regulatory action
Support programmes for patients are proliferating and regulators are looking to intervene in their international development
Corporate
Predictions 2022: What could be in store for US and international business?
Businesses will be readying themselves for growth and transformation in a year in which the world hopes to move on
Regulatory and compliance
Covid-19 and mental health figure large in latest health and safety statistics
The Health and Safety Executive has published its injury and ill-health statistics for 2021: what's changed?
Life Sciences and Healthcare
Are European advertising laws ready for patient support programmes?
The legal situation in Europe regarding advertisement of PSPs is highly fragmented with different jurisdictions taking varying approaches to address
Intellectual property
Trade secrets remain the sticking point in global debate over a vaccine IP waiver
A consensus on the vaccine IP waiver is yet to be reached, but will the cancellation of WTO's 12th Ministerial
Intellectual property
Supreme Court gives certainty to patentees in unlawful means economic tort claims
Dealing requirement upheld as an essential component of the tort, leaving intact the current system for litigating patents in the